期刊文献+

树突状细胞感染PSMA/4-1BBL基因重组腺病毒后的免疫功能变化 被引量:1

Changes in immune function of dendritic cells infected by recombinant adenovirus containing PSMA and 4-1BBL genes
下载PDF
导出
摘要 目的:观察复制缺陷型腺病毒介导的人前列腺特异性膜抗原(prostate specific membrane antigen,PSMA)基因和肿瘤坏死因子配体超家族成员4-1BB配体(4-1BB ligand,4-1BBL)基因体外共同感染的树突状细胞(dendritic cell,DC)的免疫学功能变化。方法:Ad-GFP空载体感染未成熟DC,确定最适MOI。将感染的健康志愿者外周血来源DC分为Ad-PSMA/4-1BBL-DC组(共感染组)、Ad-PSMA-DC组、Ad-4-1BBL-DC组、Ad-GFP-DC组以及未感染DC组,荧光倒置显微镜观察DC的形态学变化,流式细胞仪分析CD80、CD83、CD86等表型变化,Western blotting检测DC上PSMA和4-1BBL蛋白的表达,ELISA法检测各组DC上清的IL-12水平,CCK-8法检测各组DC刺激自体T淋巴细胞增殖能力及对人前列腺癌细胞株LNCap、Du145和22RV的细胞毒作用。结果:确定最佳MOI为200。共感染组DC表面CD80、CD83、CD86、HLA-DR共刺激分子均上调,明显高于未感染DC组[(38.72±0.99)%、(44.65±0.77)%、(63.60±0.75)%、(62.25±0.58)%vs(28.27±1.04)%、(28.08±1.16)%、(41.05±1.33)%、(46.87±1.12)%;P<0.05]。共感染组IL-12分泌水平明显高于单个基因重组腺病毒感染组及未感染组[(134.29±2.22)vs(79.51±1.60)、(70.33±1.13)、(69.67±1.43)、(28.88±2.97)pg;P<0.05]。DC∶T同一比例下,共感染组刺激自体T细胞增殖能力明显高于单感染组及未感染组(P<0.05)。PSMA/4-1BBL-DC-CTL对PSMA阳性的LNCap细胞的杀伤率明显高于对另两种PSMA阴性细胞DU145、22RV的杀伤率(P<0.05),也明显高于PSMA-DC-CTL组、4-1BBL-DC-CTL组的杀伤率(P<0.05)。结论:Ad-PSMA/4-1BBL感染后,DC不但高分泌IL-12,还能刺激和增强肿瘤特异性CTL对PSMA阳性前列腺癌细胞的杀伤作用;Ad-PSMA和Ad-4-1BBL共感染DC较单一感染DC能更有效诱导肿瘤特异性CTL。 Objective: To observe changes in immune function of dendritic cells(DCs) infected by recombinant adenovirus containing human prostate specific membrane antigen(PSMA) and 4-1BB ligand (4-1BBL) genes.Methods: The empty Ad-GFP infected immature DCs at different multiplicities of infection(MOI),and the optimal MOI was determined.DCs from peripheral blood of healthy volunteers were infected with recombinant adenoviruses at the optimal MOI.The DCs were allocated into five groups: co-infected group(Ad-PSMA/4-1BBL-DC),PSMA-infected group(Ad-PSMA-DC),4-1BBL-infected group(Ad-4-1BBL-DC),negative control group(Ad-GFP-DC) and non-infected group.Morphological changes of DCs were observed under a fluorescence microscope;and the phenotype changes of CD80,CD83,CD86 of tranfected DCs were detected by FACS,and the expressions of PSMA and 4-1BBL proteins was detected by Western blotting.IL-12 concentrations of DC supernatant in different groups were measured by ELISA.Allogenic T cell proliferations stimulated with DCs in different groups and the cytotoxic effect on prostate cancer cell lines LNCap,Du145 and 22RV were analyzed by CCK-8 assay.Results: The optimal MOI was 200.The immunophenotype expressed in the co-infected DC group,such as CD80,CD83,CD86,HLA-DR,was significantly higher than that expressed in the other DC groups([38.72±0.99]%,[44.65±0.77]%,[63.60±0.75]%,[62.25±0.58]% vs [28.27±1.04]%,[28.08±1.16%],[41.05±1.33]%,[46.87±1.12]%;P0.05).The secretion of IL-12 in supernatant was greatly higher in the co-infected group than that in single-infected group or non-infected DC group([134.29±2.22] vs [79.51±1.60],[70.33±1.13],[69.67±1.43],[28.88±2.97] pg;P0.05).At the same rate of DCs to T,the co-infected group had a more significant increase in allogenic T cell proliferation than other single-infected group or non-infected group(P0.05).The cytotoxic rate of PSMA/4-1BBL-DC-CTL against PSMA positive target LNCap cells was significantly stronger than that against PSMA negative target cells such as DU145 and 22RV cells(P0.05),and also higher than that of PSMA-DC-CTL and 4-1BBL-DC-CTL(P0.05).Conclusion: Ad-PSMA/4-1BBL-infected DCs not only own high secretion of IL-12,but also stimulate and enhance the cytotoxic effect of tumor specific CTLs against PSMA positive prostate cancer cells which highly express PSMA protein.In addition,the DCs infected with Ad-PSMA and Ad-4-1BBL induce more effective tumor specific CTLs than single-infected DCs.
出处 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2012年第1期22-28,共7页 Chinese Journal of Cancer Biotherapy
基金 辽宁省科技厅科学技术计划项目资助(No.2010225034)~~
关键词 树突状细胞 前列腺特异性膜抗原基因 4-1BBL基因 细胞毒性T淋巴细胞 前列腺癌 dendritic cell prostate specific membrane antigenen gene(PSMA) 4-1BBL gene cytotoxic T lymphocyte(CTL) prostate cancer
  • 相关文献

参考文献2

二级参考文献34

  • 1Srivastava R M,Khar A.Dendritic cells and their receptors in antitumor immune response[J].Curr Mol Med,2009,9(6):708-724.
  • 2Smits E L,Anguille S,Cools N,et al.Dendritic cellbased cancer gene therapy[J].Hum Gene Ther,2009,20(10):1106-1118.
  • 3Akbar S M,Horiike N,Onji M,et al.Dendritic cells and chronic hepatitis virus carriers[J].Interviol,2001,44(4):199-208.
  • 4Arlen P M,Gulley J L.Therapeutic vaccines for prostate cancer:a review of clinical data[J].Curr Opin Investig Drugs,2005,6(6):592-596.
  • 5Pirtskhalaishvili G,Shurin G V,Gambotto A,et al.Transduction of dendritic cells with Bcl-xL increases their resistance to prostate cancer-induced apoptosis and antitumor effect in mice[J].J Immunol,2000,165(4):1956-1964.
  • 6Kobie J J,Wu R S,Kurt R A,et al.Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines[J].Cancer Res,2003,63(8):1860-1864.
  • 7Chulso Moon,Jong Chul Park,Young Kwang Chae,et al.Current status of experimental therapeutics for prostate cancer[J].Cancer Letters,2008,266 (2):116-134.
  • 8Croft M.Co-stimulatory members of the TNFR family:keys to effective T-cell immunity?[J].Nat Rev Immunol,2003,3(8):609-620.
  • 9Rabu C,Quemener A,Jacques Y,et al.Production of recombinant human trimeric CD137L (4-1BBL).Crosslinking is essential to its T-cell co-stimulation activity[J].J Biol Chem,2005,280(50):41472-41481.
  • 10Nam K O,Kang H,Shin S M,et al.Cross-linking of 4-1BB activates TCR-signaling pathways in CD8 + T lymphocytes[J].J Immunol,2005,174(4):1898-1905.

共引文献3

同被引文献18

  • 1Graff-Dubois S,Faure 0,Gross DA,et al.Generation of CTLrecognizing an HLA-A * 0201-restricted epitope shared by MAGE-Al,-A2 ,-A3 ,-A4 ,-A6 ,-A10, and-A12 tumor antigens:Im-plication in a broad-spectrum tumor immunotherapy[J].J Immu-nol, 2002,169(1):575-580.
  • 2Shantha Kumara HM, Grieco MJ, Caballero OL, et al.MAGE-A3is highly expressed in a subset of colorectal cancer patients[J].Cancer Immun, 2012, 12(1):16-25.
  • 3Morgan RA,Chinnasamy N,Abate-Daga D,et al.Cancer regre-ssion and neurological toxicity following anti-MAGE-A3 TCR genetherapy[J].J Immunother, 2013 , 36(2):133-151.
  • 4Moeller I,Spagnoli GC, Finke J, et al.Uptake routes of tumor-antigen MAGE-A3 by dendritic cells determine priming of naive T-cell subtypes[J].Cancer Immunol Immunother, 2012,61(11):2079-2090.
  • 5Tenbusch M, Nchinda G, Storcksdieck Genannt Bonsmann M,et al.Targeting the antigen encoded by adenoviral vectors to theDEC205 receptor modulates the cellular and humoral immuneresponse[J].Int Immunol, 2013,25(4):247-258.
  • 6Granio 0,Excoffon KJDA, Henning P, et al.Adenovirus 5-fiber35 chimeric vector mediates efficient apical correction of the cysticfibrosis transmembrane conductance regulator defect in cysticfibrosis primary airway epithelia[J].Hum Gene Ther, 2010, 21(3); 251-269.
  • 7Cayer MP, Samson M, Bertrand C, et al.Suppression of proteinphosphatase 2A activity enhances Ad5/F35 adenovirus transduc-tion efficiency in normal human B lymphocytes and in Raji cells[J].J Immunol Methods, 2012,376(1/2):113-124.
  • 8Mailliard RB, Dallal RM, Son YI, et al.Dendritic cells promoteT-cell survival or death depending upon their maturation state andpresentation of antigen[J].Immunol Invest, 2000, 29(2):177-185.
  • 9Mbeunkui F, Johann DJ Jr.Cancer and the tumor microenviron-ment:A review of an essential relationship[J].Cancer Chemo-ther Pharmacol, 2009,63(4):571-582.
  • 10Hadrup SR.The antigen specific composition of melanoma tumorinfiltrating lymphocytes?[J].Oncoimmunology, 2012,1(6):935-936.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部